Author

A. Evers

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Biochemistry· 1 Biophysics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell signaling & trafficking· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Approach:biophysical modeling· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

A. L. Germann· 1 shared A. Wegener· 1 shared C. Schroeter· 1 shared D. E. Reichert· 1 shared D. Elter· 1 shared D. F. Covey· 1 shared D. Koenning· 1 shared D. Schwarz· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiophysics

A. L. Germann

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

PROxAb Shuttle: A non-covalent plug-and-play platform for the rapid generation of tumor-targeting antibody-PROTAC conjugates

H. Schneider, S. Jaeger, D. Koenning, N. Rasche, C. Schroeter, D. Elter, A. Evers, M. Lecomte, F. Riccardi Sirtori, D. Schwarz, A. Wegener, I. Hartung, M. Rieker

This paper introduces a platform for creating tumor-targeting antibody-PROTAC conjugates that enhances bioavailability and specificity without modifying PROTACs or antibodies.

bioRxiv · Sep 29, 2023 · PreprintBiochemistry

The SARS-CoV-2 accessory factor ORF7a downregulates MHC class I surface expression

S. Zheng, H. de Buhr, P. Praest, A. Evers, I. Brak Boer, M. van Grinsven, Y. Longo, L. de Vries, W. Nijenhuis, L. C. Kapitein, J. M. Beekman, M. Nijhuis, I. Drexler, E. J. Wiertz, R. J. Lebbink

This study identifies SARS-CoV-2 ORF7a as a viral factor that downregulates MHC class I surface expression, impairing antigen presentation and immune surveillance.

bioRxiv · May 29, 2022 · PreprintMicrobiology

Matrix-Assisted Laser Desorption-Ionization Time-of-Flight mass spectrometry using a custom-made database, biomarker assignment, or mathematical classifiers does not differentiate Shigella spp. and Escherichia coli

M. J. C. van den Beld, J. W. A. Rossen, A. Evers, M. A. M. D. Kooistra-Smid, F. A. G. Reubsaet

This study evaluates methods to distinguish Shigella spp. and E. coli using MALDI-TOF MS, finding none effectively differentiate them due to their close relation.

bioRxiv · Mar 4, 2021 · PreprintMicrobiology

Site-specific effects of neurosteroids on GABAA receptor activation and desensitization

Y. Sugasawa, W. W. Cheng, J. Bracamontes, Z.-W. Chen, L. Wang, A. L. Germann, S. R. Pierce, T. C. Senneff, K. Krishnan, D. E. Reichert, D. F. Covey, G. Akk, A. Evers

This study identifies how neurosteroids interact with three distinct sites on the GABAA receptor, influencing activation and desensitization, and shows that site-specific binding determines their functional effects.

bioRxiv · Apr 27, 2020Biophysics